Investors in the commercial space industry are showing increased interest in Rocket Lab USA, Inc. (NASDAQ: RKLB). Due to its focus on innovation and market demands, the company has grown from a small ...

Zai Lab shows strong growth in oncology/autoimmune drugs; reduced losses and efficient operations evident in Q3 results. Healthy financial status with a strong current ratio of 7.68; reduced R&D ...

As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and ...

Wall Street loves a good David versus Goliath story. But what happens when two Davids are battling entirely different giants? That's the compelling dynamic between Rocket Lab USA (NASDAQ: RKLB) and ...

Rocket Lab is on track for 'a similarly aggressive growth trajectory as SpaceX,' writes KeyBanc Capital Markets analyst Michael Leshock Rocket Lab USA Inc.'s stock initially tumbled in the wake of the ...

Last week, Rocket Lab RKLB scored a satellite contract with the U.S. Space Development Agency, boosting the space stock to a ...

Zai lab's diversified pipeline, strong partnerships, and proven track record of successful drug development make it an attractive investment opportunity in the biotech industry. The recent acceptance ...

Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the ...

U.S. stocks have fallen sharply since the start of 2025. This pullback has created compelling buying opportunities in leading space companies. Rocket Lab USA and Intuitive Machines both offer ...

Rocket Lab USA Inc.’s stock initially tumbled in the wake of the company’s fourth-quarter results Thursday, weighed down by weak outlook, although an analyst KeyBanc Capital Markets believes the ...